A Phase 1, Randomized, Double-Blind, Placebo- and Active- Controlled, Crossover Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Male and Female Adult Subjects.

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo- and Active- Controlled, Crossover Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Male and Female Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 May 2014

At a glance

  • Drugs Acotiamide (Primary) ; Moxifloxacin
  • Indications Bacterial infections; Dyspepsia
  • Focus Pharmacodynamics
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 16 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Apr 2009 Actual end date changed from Mar 2009 to Apr 2009 as reported by ClinicalTrials.gov.
    • 12 Mar 2009 Planned number of patients changed from 72 to 80 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top